Antara Capital LP Uni Qure N.V. Transaction History

Antara Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $2.88 Million - $4.24 Million	-110,899 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $3.32 Million - $4.12 Million	110,899 New	110,899 $3.42 Million
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $3.54 Million - $5.07 Million	-100,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $3.6 Million - $4.77 Million	100,000 New	100,000 $3.68 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

Stay updated on Antara Capital LP with notifications on news.